Skip to content

Efficacy of L-menthol in endoscopic diagnosis for gastric neoplasms

Efficacy of L-menthol in endoscopic diagnosis for gastric neoplasms - L-menthol method for gastric neoplasms

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020012
Enrollment
50
Registered
2015-12-01
Start date
2015-12-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric neoplasm

Interventions

Biopsy of gastric neoplasms and surrounding non-tumorous mucosa

Sponsors

Depertment of Gastroenterology and Rheumatology, Fukushima Medical University School of medicine and Depertment of Endoscopy, Fukushima Medical University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Diameter of gastric neoplasm is smaller than 30mm, and depth of tumor invasion is from mucosa to submucosa 2.Patients who agree the content of this study

Exclusion criteria

Exclusion criteria: 1.The past medical history of gastric operation 2.Allergy of L-menthol 3.Patients who could not agree the content of this study 4.Patients that researchers admit inadequate for candidates

Design outcomes

Primary

MeasureTime frame
Evaluation objectively the effectiveness of L-menthol for identifying gastric neoplasms and determining neoplasm margins. Using "Color difference", digitize color difference, and bigger numerical data is more clear determining neoplasm margins. Calculate "Color difference" of each L-menthol spreyed neoplasm and not, and compare two values. Same as do for NBI.

Secondary

MeasureTime frame
Evaluation that whether "Color difference" is had an effect by morphological type, tissue type, location, atrophy of surrounding gastric mucosa and Helicobacter pylori inffection.

Countries

Japan

Contacts

Public ContactKikuchi Hitomi

Fukushima Medical University School of medicine Depertment of Gastroenterology and Rheumatology

hitomi25@fmu.ac.jp024-547-1202

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026